A new American Cancer Society report raises concerns over missed screenings for breast, cervical, and prostate cancer during the pandemic.February 24, 2023Check out STAT+Sponsored By Adobe American Cancer Society warns about potential impact of missed screenings during Covid Without make-up visits, some patients may miss out on routine screenings detecting early-stage cancer or precancerous lesions. By Angus Chen STAT+ | Lawmakers urge U.S. patent office to scrutinize Merck over 'abuse' of the system Lawmakers are raising questions about the patent strategies deployed by Merck for Keytruda, its cancer drug. By Ed Silverman STAT+ | More physicians are calling for fallopian tube removal to prevent ovarian cancer Some doctors recommend that women who are done with childbearing, and undergoing other pelvic surgeries, have their tubes removed. By Zeina Mohammed — Boston Globe Ruby Wallau for STAT STAT+ | Once high-flying Rubius to shut down. Its flameout is a lesson for biotech The flameout of Rubius, once valued at $2 billion, is the unsurprising result of a particularly ignominious biotech financing trend. By Adam Feuerstein More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments